# Healthpeak (DOC) — Analyst Forecast

DOC · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/doc/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Hold | 8 | 14 | 0 | 22 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $20.00 | $22.11 | $24.00 | 9 |

Last price $18.96 (as of Oct 15, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 13, 2026 | Barclays | Maintained | Equal-Weight | $21.00 |
| Oct 13, 2026 | UBS | Maintained | Neutral | $20.00 |
| Sep 21, 2026 | Evercore ISI Group | Maintained | In-Line | $22.00 |
| Sep 15, 2026 | Jefferies | Initiated Coverage | Hold | $21.00 |
| Aug 31, 2026 | Barclays | Maintained | Equal-Weight | $24.00 |
| Aug 13, 2026 | Baird | Maintained | Outperform | $24.00 |
| Aug 11, 2026 | Citigroup | Maintained | Neutral | $22.00 |
| Aug 10, 2026 | RBC Capital | Maintained | Outperform | $24.00 |
| Aug 6, 2026 | Cantor Fitzgerald | Maintained | Neutral | $23.00 |
| Jul 15, 2026 | Wells Fargo | Maintained | Equal-Weight | $22.00 |
| Jul 8, 2026 | UBS | Maintained | Neutral | $21.50 |
| Jul 7, 2026 | Barclays | Initiated Coverage | Overweight → Equal-Weight | $23.00 |
| Jul 6, 2026 | Mizuho | Maintained | Outperform | $24.00 |
| Jun 24, 2026 | JP Morgan | Maintained | Neutral | $21.00 |
| Jun 17, 2026 | Raymond James | Maintained | Outperform → Market Perform | — |
| Jun 15, 2026 | BMO Capital | Maintained | Outperform | $24.00 |
| Jun 11, 2026 | Morgan Stanley | Downgraded | Overweight → Equal-Weight | $22.00 |
| Jun 1, 2026 | Wells Fargo | Maintained | Equal-Weight | $20.00 |
| May 27, 2026 | Scotiabank | Maintained | Sector Perform | $21.00 |
| May 22, 2026 | Morgan Stanley | Maintained | Overweight | $20.00 |

## Frequently Asked Questions

### What is the price target for DOC stock?

The average 12-month analyst price target for Healthpeak (DOC) is $22.11, with a high estimate of $24.00 and a low of $20.00, across 9 analysts.

### Is DOC a buy, sell, or hold?

Analysts covering Healthpeak currently average a Hold rating: 8 buy, 14 hold and 0 sell, from 22 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for DOC?

The average price target of $22.11 implies 16.62% upside from the last price of $18.96.

### What is the latest analyst rating on DOC?

On Oct 13, 2026, Barclays maintained Healthpeak at Equal-Weight with a price target of $21.00.

## Similar Stocks

- [MGEE](https://www.lighthorse.io/tickers/mgee) — MGE Energy Inc. - Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).